Osteoarthritis Drug Receives Fast Track Designation from FDA

In late November 2018, the FDA announced that it was granting Fast Track designation to an investigational drug for the treatment of osteoarthritis (OA). The drug, developed by Galapagos, is known by its identifier GLPG1972/S201086.  This drug is one to watch, since it has a novel mechanism of action for this therapeutic category. GLPG1972/S201086 is […]

Read more detail on Recent Health Care Law posts –

Related news:

This entry was posted in Health Law and tagged , , , , , . Bookmark the permalink.

Leave a Reply